Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials

BACKGROUND: Ivermectin which was widely considered as a potential treatment for COVID-19, showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials to evaluate the effectiveness of this drug in the midst of the pandemic, while difficult, has been urgently need...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezai, Mohammad Sadegh, Ahangarkani, Fatemeh, Hill, Andrew, Ellis, Leah, Mirchandani, Manya, Davoudi, Alireza, Eslami, Gohar, Roozbeh, Fatemeh, Babamahmoodi, Farhang, Rouhani, Nima, Alikhani, Ahmad, Najafi, Narges, Ghasemian, Roya, Mehravaran, Hossein, Hajialibeig, Azin, Navaeifar, Mohammad Reza, Shahbaznejad, Leila, Rahimzadeh, Golnar, Saeedi, Majid, Alizadeh-Navai, Reza, Moosazadeh, Mahmood, Saeedi, Shahab, Razavi-Amoli, Seyedeh-Kiana, Rezai, Shaghayegh, Rostami-Maskopaee, Fereshteh, Hosseinzadeh, Fatemeh, Movahedi, Faezeh Sadat, Markowitz, John S., Valadan, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244711/
https://www.ncbi.nlm.nih.gov/pubmed/35783616
http://dx.doi.org/10.3389/fmed.2022.919708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244711/
https://www.ncbi.nlm.nih.gov/pubmed/35783616
http://dx.doi.org/10.3389/fmed.2022.919708

Ejemplares similares